JPRN-UMIN000003041已完成未知
An exploratory study of administration of foscarnet for cytomegalovirus infection and human herpes virus type 6 infection after hematopoietic stem cell transplantation.. - Foscarnet for CMV and HHV6 infection after HSCT.
niversity of Tokyo Hospital, Depaartment of Hematology and Oncology0 个研究点目标入组 10 人开始时间: 2010年1月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Allergy to foscarnet. 2. The creatinine clearance is less than 0.4mL/min/kg. 3. HIV-positive patients. 4. A woman during pregnancy or potential pregnancy. 5. Patients who are recognized as inadaptable for this trial.
研究者
相似试验
已完成
1 期
Prospective study of Foscarnet sodium administration for the prevention of HHV-6 encephalitis after hematopoietic stem cell transplantatioJPRN-UMIN000001346Cellular transplantation biology, Graduate School of Medical Science, Kanazawa University10
尚未招募
不适用
The clinical effects of foscarnet prophylaxis for human herpes virus type 6 associated limbic encephalitis after umbilical cord blood transplantatioHuman herpes virus type 6-associated limbic encephalitis after umbilical cord blood transplantationJPRN-UMIN000010591Toranomon Hospital Department of Hematology100
已完成
不适用
Prospective study of preventive Foscarnet sodium administration to confirm the safety and preventive effect of HHV-6 encephalitis after hematopoietic stem cell transplantatioHematologic disorder, who receive hematopoietic stem cell transplantation (HSCT) from alternative donorJPRN-UMIN000001706Cellular transplantation biology, Graduate School of Medical Science, Kanazawa University10
已完成
不适用
A study for evaluating the effects of intake of food containing lactic acid bacteria on immunological functions - A randomized, single-blind, placebo-controlled trial.JPRN-UMIN000042024otte Co., Ltd.20
已完成
不适用
A study for evaluating the effects of intake of food containing lactic acid bacteria and oligosaccharide on intestinal environment. A placebo-controlled, randomized, double-blind, cross-over trial.Subjects with a tendency for constipationJPRN-UMIN000037928KSO Corporation22